Urologix Inc. (NSDQ:ULGX) reported “disappointing” second-quarter results on Tuesday, posting a net loss of $712,000.
The Plymouth, Mass.-based company develops devices for treating enlarged prostate, or benign prostatic hyperplasia. Its Targis System uses microwave energy to heat and destroy enlarged prostate tissue as an alternative to pharmaceutical treatment.